source
- Analysis questions expanded orphan drug exemptions under recent legislationEd Silverman, a Pharmalot columnist, examined a provision in the One Big Beautiful Bill Act that keeps certain orphan drugs out of Medicare price negotiations. The Inflation Reduction Act, which b…
- Smith & Nephew lowers 2026 sales outlook as US knee implant revenue falls 7%Smith & Nephew announced a revision to its 2026 sales outlook, now expecting underlying revenue growth of about 4% versus the prior 6% target. The change follows a second‑quarter report showing re…